Bristol Up As New Therapy’s Phase-3 Trial In Lymphoma Is Positive
- Date: 10-Jun-2021
- Source: Investing.com
- Sector:Financial Markets
- Country:Middle East
Bristol Up As New Therapy’s Phase-3 Trial In Lymphoma Is Positive
By Dhirendra Tripathi
Investing.com – Bristol-Myers Squibb (NYSE:) shares were up more than 3% Friday as the company's phase-3 trial of a therapy to treat lymphoma revealed positive results.